Related Experiment Video
Updated: May 7, 2026
07:57
Malachite Green Assay for the Discovery of Heat-Shock Protein 90 Inhibitors
Published on: January 20, 2023
Targeting heat shock protein 90 for malaria
Anup S Ramdhave1, Dhaval Patel, I Ramya
1Departments of Pharmaceutical Chemistry and Pharmaceutical Biotechnology, SPP School of Pharmacy and Technology Management, SVKM's NMIMS, V. L. Mehta Road, Vile Parle (West), Mumbai-400056, India. prashant.kharkar@nmims.edu.
Mini Reviews in Medicinal Chemistry
|September 28, 2013
Summary
Heat shock protein 90 (Hsp90) inhibitors show promise as novel antimalarial agents. Targeting PfHsp90 could overcome drug resistance in Plasmodium falciparum, improving malaria treatment outcomes.
Area of Science:
- Molecular Biology
- Parasitology
- Drug Discovery
Background:
- Heat shock protein 90 (Hsp90) is a crucial molecular chaperone in eukaryotes, regulating vital cellular processes.
- Anomalous Hsp90 expression is linked to various diseases, including malaria.
- Existing antimalarial therapies face challenges due to increasing drug resistance in Plasmodium species.
Purpose of the Study:
- To explore the potential of Hsp90 inhibitors as novel antimalarial agents.
- To investigate the role of Plasmodium falciparum Hsp90 (Pfhsp90) in parasite development.
- To identify Hsp90 as a potential therapeutic target for malaria.
Main Methods:
- Review of current research on Hsp90 function and its inhibitors.
- Analysis of PfHsp90's role in Plasmodium falciparum development, particularly during febrile episodes.
- Examination of ongoing drug development for Hsp90 inhibitors in antimalarial and anticancer applications.
Main Results:
- Hsp90 is essential for Plasmodium parasite development and survival.
- Pfhsp90 plays a critical role in regulating parasite growth during malaria-associated fevers.
- Numerous Hsp90 inhibitors are in development for both antimalarial and anticancer therapies.
Conclusions:
- Hsp90 represents a promising therapeutic target for combating malaria.
- Developing novel Hsp90 inhibitors could offer an effective strategy against drug-resistant malaria.
- Further research into Hsp90 inhibitors may lead to improved malaria treatment outcomes.
